Skip to main navigation Skip to search Skip to main content

Serological biomarkers for development of Rheumatoid arthritis related interstitial lung disease

  • Adam Young
  • , Elena Nikiphorou
  • , E. Chan
  • , V. Saravanan
  • , J. Dawson
  • , N. Sathi
  • , F. Woodhead
  • , M. Nisar
  • , S. Arthanari
  • , Y. Ahmad
  • , C. Kelly

Research output: Contribution to journal › Meeting abstract

Abstract

Background/Purpose: Interstitial Lung Disease (ILD) is the commonest manifestation of lung disease in Rheumatoid Arthritis (RA) and the only complication reported to be increasing in prevalence, accounting for 6% of all RA deaths. High resolution computed tomography (HRCT) confirmed 25% of RA patients had radiological evidence of ILD. This study examines predictive factors for RA-ILD in a large multi centre UK cohort.
Original languageEnglish
JournalArthritis and Rheumatism
Publication statusPublished - 30 Oct 2013
Event2013 ACR/ARHP Annual Meeting - San Diego, United States
Duration: 25 Oct 2013 → 30 Oct 2013

Fingerprint

Dive into the research topics of 'Serological biomarkers for development of Rheumatoid arthritis related interstitial lung disease'. Together they form a unique fingerprint.

Cite this